Latest filing published 30 Aug 2024 for Y-mAbs Therapeutics, Inc., €691k.
Filing timeline
BuySaleInsider track record
Torben Lund-Hansen: trading record in brief
This profile gathers the share dealings of Torben Lund-Hansen in Y-mAbs Therapeutics, Inc. The record holds 4 filings, for trades running from 17 January 2023 to 28 August 2024.
No open-market purchase appears, only 1 sale worth €691k. Outside the open market, there are 2 share grants and 1 option exercise. So far in 2024, the count stands at no purchases and 1 sale.
The newest entry dates from 30 August 2024: an open-market sale of €691k, in Y-mAbs Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Torben Lund-Hansen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$15.3777.8% of flowCommon StockSEC:0001415889-24-022629:1
- 50,000 shares@ US$4.38100.0% of flowCommon StockSEC:0001415889-24-022629:0
- 17,800 shares0Common StockSEC:0001415889-24-001646:0
- 17,800 shares0Common StockSEC:0001104659-23-005036:0
4 of 4 declarations